Table 5 Description of certain ADRs as a cause of admittance
ADR (No. of patients) | Class of drugs (No. of patients with ADR/No. of patients with potentially preventable ADR) |
|---|---|
Cardiovascular disorders | Â |
   Bradycardia (4) | Beta-adrenergic blocker (2/2) * |
| Â | Beta-adrenergic blocker and digoxin (2/2) * |
Gastrointestinal disorder | Â |
   Gastrointestinal bleeding (12) | Acetylsalicylic acid (4/4) * |
| Â | Acetylsalicylic acid with NSAID (1/1) * |
| Â | NSAID (5/4) * |
| Â | Warfarin (2/2) * |
   Liver failure (1) | Antifungal agent (1/0) |
Renal disorders | Â |
   Renal failure (1) | Antineoplastic agent (1/0) |
Haematological disorders | Â |
   Anaemia (2) | Antineoplastic agent (1/1) * |
| Â | Immunosuppressive agent (1/1) * |
   Pancytopenia (1) | Antineoplastic agent (1/1) * |
Metabolic disorders | Â |
   Hypoglycaemia (3) | Insulin (2/2) * |
| Â | Insulin and sulphonyurea (1/1) * |
   Hyperglycaemia (4) | Corticosteroid (4/4) * |
   Hypokaliemia (1) | Diuretic (1/1) * |
   Hyperkaliemia (1) | ACE inhibitor and spironolactone (1/1) * |